Identification of Activated Protein Kinase Cα (PKCα) in the Urine of Orthotopic Bladder Cancer Xenograft Model as a Potential Biomarker for the Diagnosis of Bladder Cancer
Open Access
- 27 August 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (17) , 9276
Abstract
Bladder cancer has a high recurrence rate; therefore, frequent and effective monitoring is essential for disease management. Cystoscopy is considered the gold standard for the diagnosis and continuous monitoring of bladder cancer. However, cystoscopy is invasive and relatively expensive. Thus, there is a need for non-invasive, relatively inexpensive urinary biomarker-based diagnoses of bladder cancer. This study aimed to investigate the presence of activated protein kinase Cα (PKCα) in urine samples and the possibility of PKCα as a urinary biomarker for bladder cancer diagnosis. Activated PKCα was found to be present at higher levels in bladder cancer tissues than in normal bladder tissues. Furthermore, high levels of activated PKCα were observed in urine samples collected from orthotopic xenograft mice carrying human bladder cancer cells compared to urine samples from normal mice. These results suggest that activated PKCα can be used as a urinary biomarker to diagnose bladder cancer. To the best of our knowledge, this is the first report describing the presence of activated PKCα in the urine of orthotopic xenograft mice.Keywords
Funding Information
- Japan Society for the Promotion of Science (19K09692, 19H04488, 21K12685)
- Japan Agency for Medical Research and Development (JP20hm0102067)
This publication has 32 references indexed in Scilit:
- Bladder Cancer in 2010: How Far have We Come?CA: A Cancer Journal for Clinicians, 2010
- Gold nanoparticle-based colorimetric assay for cancer diagnosisBiosensors and Bioelectronics, 2010
- Accuracy of Urine Cytology and the Significance of an Atypical CategoryAmerican Journal of Clinical Pathology, 2009
- Design of Polymeric Carriers for Cancer-Specific Gene Targeting: Utilization of Abnormal Protein Kinase Cα Activation in Cancer CellsJournal of the American Chemical Society, 2008
- Structural Basis of Protein Kinase C Isoform FunctionPhysiological Reviews, 2008
- A short peptide is a protein kinase C (PKC) α‐specific substrateProteomics, 2008
- Analysis of Posttranslational Modifications of Proteins by Tandem Mass SpectrometryBioTechniques, 2006
- Role of protein kinase C-alpha in superficial bladder carcinoma recurrenceUrology, 2005
- Tumor Grade-Dependent Alterations in the Protein Kinase C Isoform Pattern in Urinary Bladder CarcinomasEuropean Urology, 2004
- Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analysesUrology, 2003